These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Enhancement of the curative activity of primaquine by concomitant administration of mirincamycin. Schmidt LH Antimicrob Agents Chemother; 1985 Feb; 27(2):151-7. PubMed ID: 3885847 [TBL] [Abstract][Full Text] [Related]
25. Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro. Maher SP; Vantaux A; Chaumeau V; Chua ACY; Cooper CA; Andolina C; Péneau J; Rouillier M; Rizopoulos Z; Phal S; Piv E; Vong C; Phen S; Chhin C; Tat B; Ouk S; Doeurk B; Kim S; Suriyakan S; Kittiphanakun P; Awuku NA; Conway AJ; Jiang RHY; Russell B; Bifani P; Campo B; Nosten F; Witkowski B; Kyle DE Sci Rep; 2021 Oct; 11(1):19905. PubMed ID: 34620901 [TBL] [Abstract][Full Text] [Related]
26. Primaquine in vivax malaria: an update and review on management issues. Fernando D; Rodrigo C; Rajapakse S Malar J; 2011 Dec; 10():351. PubMed ID: 22152065 [TBL] [Abstract][Full Text] [Related]
28. A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax. Gogtay N; Garg M; Kadam V; Kamtekar K; Kshirsagar NA Trans R Soc Trop Med Hyg; 1998; 92(3):341. PubMed ID: 9861412 [No Abstract] [Full Text] [Related]
29. Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malaria. Kocken CH; Remarque EJ; Dubbeld MA; Wein S; van der Wel A; Verburgh RJ; Vial HJ; Thomas AW Antimicrob Agents Chemother; 2009 Feb; 53(2):421-7. PubMed ID: 19015340 [TBL] [Abstract][Full Text] [Related]
30. Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum. Wampfler R; Hofmann NE; Karl S; Betuela I; Kinboro B; Lorry L; Silkey M; Robinson LJ; Mueller I; Felger I PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005753. PubMed ID: 28732068 [TBL] [Abstract][Full Text] [Related]
31. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi. Amanzougaghene N; Tajeri S; Franetich JF; Ashraf K; Soulard V; Bigeard P; Guindo CO; Bouillier C; Lemaitre J; Relouzat F; Legrand R; Kocken CHM; Zeeman AM; Roobsoong W; Sattabongkot J; Yang Z; Snounou G; Mazier D Int J Antimicrob Agents; 2024 May; 63(5):107112. PubMed ID: 38367843 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia. Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832 [TBL] [Abstract][Full Text] [Related]
33. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Goller JL; Jolley D; Ringwald P; Biggs BA Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026 [TBL] [Abstract][Full Text] [Related]
34. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India. Yadav RS; Ghosh SK J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158 [TBL] [Abstract][Full Text] [Related]
35. Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates. Hobbs CV; Dixit S; Penzak SR; Sahu T; Orr-Gonzalez S; Lambert L; Zeleski K; Chen J; Neal J; Borkowsky W; Wu Y; Duffy PE PLoS One; 2014; 9(12):e115506. PubMed ID: 25541998 [TBL] [Abstract][Full Text] [Related]
36. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil. Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991 [TBL] [Abstract][Full Text] [Related]
37. Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax. Campo B; Vandal O; Wesche DL; Burrows JN Pathog Glob Health; 2015 May; 109(3):107-22. PubMed ID: 25891812 [TBL] [Abstract][Full Text] [Related]
38. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326 [TBL] [Abstract][Full Text] [Related]
39. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil. Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631 [TBL] [Abstract][Full Text] [Related]
40. Plasmodium cynomolgi: gametocytocidal activity of the anti-malarial compound CDRI 80/53 (elubaquine) in rhesus monkeys. Puri SK; Dutta GP Exp Parasitol; 2005 Sep; 111(1):8-13. PubMed ID: 16005457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]